Global Regulatory & Evidence Group Expertise

Policy & Government Affairs

Evidence and strategy for the public-policy environment.

What we solve

Policy questions rarely stay inside policy.

Legislation, regulation, scientific evidence, public-health priorities, and stakeholder interests often move together. GR&EG helps pharmaceutical and government stakeholders understand those intersections so they can anticipate consequences, communicate evidence clearly, and make better-informed policy decisions.

Policy uncertainty

Understand what a proposed or emerging policy could mean before the impact is fully defined.

Stakeholder complexity

Map the interests, incentives, evidence needs, and influence of public-sector stakeholders.

Evidence-to-policy gaps

Translate scientific and technical evidence into a form policymakers can actually use.

Common client questions

Questions we help clients answer

How could this policy change affect our regulatory, evidence, or market strategy?

What does this legislation mean in practice—not just on paper?

Which stakeholders are most likely to shape the outcome, and what do they need to understand?

What evidence would make this policy argument more credible or decision-ready?

Where are the public-health implications that could change how this issue is viewed?

How should we prepare for multiple policy outcomes when the environment is still uncertain?

Capabilities

How we help

Legislative & policy analysis

Interpret proposed and enacted policy through the lens of healthcare operations, regulation, and strategy.

Regulatory impact assessment

Evaluate how policy developments could alter regulatory expectations, evidence needs, or market conditions.

Public-health strategy

Connect policy choices with population-level consequences, implementation realities, and health outcomes.

Evidence for policymakers

Translate scientific, clinical, economic, and real-world evidence into decision-ready public-sector insight.

Stakeholder & coalition strategy

Understand who matters, what influences them, and where alignment or opposition may emerge.

Government-facing scientific communications

Prepare clear, credible materials for legislative, agency, and public-sector audiences.

How GR&EG approaches it

Separate what has changed from what may change—and what each possibility means.

We combine policy analysis, evidence, regulatory context, and stakeholder intelligence to distinguish immediate implications from emerging signals and longer-term scenarios.

01 — SCAN

Understand the landscape

Identify relevant legislation, regulation, stakeholders, evidence, and public-health context.

02 — INTERPRET

Define the implications

Translate policy language and signals into practical consequences for the issue at hand.

03 — PREPARE

Build the strategy

Develop evidence, stakeholder, communication, and scenario plans around likely outcomes.

04 — ADAPT

Stay aligned

Update the strategy as policy, regulation, evidence, and stakeholder positions evolve.

Related expertise

The answer rarely lives in one discipline.

Policy Insight

Keeping Regulatory Strategy Aligned With Public Policy

Why policy context increasingly belongs in the regulatory strategy conversation.

Read insight

Start a conversation

Trying to understand what a policy change means before the answer is obvious?

We can help connect legislation, evidence, stakeholders, regulation, and public-health implications into a clearer strategic view.

Discuss Your Needs →